Soleno Therapeutics Inc.

NASDAQ: SLNO · Real-Time Price · USD
71.63
-5.73 (-7.41%)
At close: Aug 15, 2025, 3:59 PM
72.00
0.52%
After-hours: Aug 15, 2025, 07:57 PM EDT

Soleno Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
32.66M n/a n/a n/a n/a n/a 3.45M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
696K n/a n/a n/a 494K 490K 489K 557K 598K 568K 519K 565K 563K 563K 516K 561K 565K 565K
Gross Profit
31.96M n/a n/a n/a -494K -490K 2.96M -557K -598K -568K -519K -565K -563K -563K -516K -561K -565K -565K
Operating Income
-6.53M -45.74M -59.12M -80.21M -23.23M -21.4M -12.83M -10.86M -8.62M -8.47M -5.61M -6.24M -6.78M 5.77M -3M -8.29M -11.09M 9.16M
Interest Income
3.19M n/a 3.37M 3.6M 3.01M 2.08M 2.14M 174K 147K 113K 125K 101K 52K 22K 34K 34K 41K 1K
Pretax Income
-4.71M -43.77M -55.98M -76.62M -21.85M -21.4M -11.3M -10.86M -8.47M -8.36M -5.49M -6.13M -6.72M -5.72M -2.83M -8.14M -10.99M -8.95M
Net Income
-4.71M -43.77M -55.98M -76.62M -21.85M -21.4M -11.3M -10.86M -8.47M -8.35M -3.75M -6.29M -7.85M -3.91M -2.83M -8.14M -10.99M -8.95M
Selling & General & Admin
28.24M 29.26M 37.3M 49.2M 10.39M 8.47M 3.65M 3.32M 3.17M 2.85M 2.4M 2.33M 2.47M 2.64M 2.6M 2.77M 2.46M 2.98M
Research & Development
9.15M 13.52M 21.49M 30.14M 12.34M 14.6M 8.69M 6.04M 5.14M 5.32M 3.81M 3.77M 3.7M 3.99M 3.73M 4.97M 5.59M 7.16M
Other Expenses
1.1M 2.97M 327K 877K n/a 401K n/a 1.02M 313K 299K -132K 132K 616K n/a n/a 551K 3.03M n/a
Operating Expenses
38.49M 45.74M 59.12M 80.21M 22.74M 23.48M 12.34M 10.38M 8.31M 8.17M 6.21M 6.1M 6.16M 6.63M 6.33M 7.74M 8.05M 10.14M
Interest Expense
1.38M -1.36M 231K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a -494K n/a -489K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
39.18M 45.74M 60.27M 80.21M 23.23M 23.48M 12.83M 10.38M 8.31M 8.17M 6.21M 6.1M 6.16M 6.63M 6.33M 7.74M 8.05M 10.14M
Income Tax Expense
n/a n/a n/a n/a n/a 1.19M 2M -2.16M n/a -5K -1.74M 159K 1.12M -1.81M n/a n/a n/a -1.19M
Shares Outstanding (Basic)
50.48M 46.18M 43.92M 41.88M 38.63M 36.21M 34.39M 11.43M 10.42M 9.45M 9.44M 9.42M 9.34M 5.33M 5.32M 5.32M 5.32M 5.31M
Shares Outstanding (Diluted)
50.48M 46.18M 43.92M 41.88M 38.63M 36.21M 34.44M 11.44M 10.42M 9.45M 9.44M 9.42M 9.34M 5.33M 5.32M 5.32M 5.32M 5.31M
EPS (Basic)
-0.09 -0.95 -1.27 -1.83 -0.57 -0.59 -0.33 -0.95 -0.81 -0.88 -0.4 -0.67 -0.84 -0.73 -0.53 -1.53 -2.07 -1.69
EPS (Diluted)
-0.09 -0.95 -1.27 -1.83 -0.57 -0.59 -0.33 -0.95 -0.81 -0.88 -0.4 -0.67 -0.84 -0.73 -0.53 -1.53 -2.07 -1.69
EBITDA
-2.83M -41.91M -55.25M -78.83M -22.74M -22.58M -12.34M -8.87M -7.88M -7.68M -5.72M -5.57M -5.67M -6.14M -5.84M -7.24M -7.56M -9.65M
EBIT
-3.33M -42.41M -55.75M -79.33M -23.23M -23.07M -12.83M -9.36M -8.31M -8.36M -6.21M -6.1M -6.16M -6.63M -6.33M -7.74M -8.05M -10.14M
Depreciation & Amortization
502K 504K 503K 500K 494K 490K 489K 557K 598K 568K 519K 565K 563K 563K 516K 561K 565K 565K